Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Insulin Producing MSC Transplantation in Youth With Type 1 Diabetes
NCT06951074Phase 3Recruiting
- Sponsor
- Ain Shams University
- Start
- Apr 2025
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Ain Shams University. Primary endpoints: Insulin producing mesenchymal stem cells efficacy in insulin production in vitro at 1 year and Insulin producing mesenchymal stem cells efficacy in insulin production in vivo at 1 year. Started Apr 2025; status: recruiting.
02
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06951074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06951074.